Crescita Therapeutics Inc. (TSX:CTX)

Market Cap	8.58M
Revenue (ttm)	20.27M
Net Income (ttm)	-1.33M
Shares Out	18.87M
EPS (ttm)	-0.07
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	76,638
Average Volume	20,924
Open	0.4550
Previous Close	0.4550
Day's Range	0.4550 - 0.4550
52-Week Range	0.4450 - 0.6400
Beta	1.14
RSI	42.51
Earnings Date	Nov 7, 2025

About Crescita Therapeutics

Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. It operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The company owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers and DuraPeel that supports the development of patented formulations to facilitate the delivery of active ingredients into or through the skin. The compan...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2016
• Country: Canada
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: CTX

Financial Performance

In 2024, Crescita Therapeutics's revenue was 19.58 million, an increase of 11.75% compared to the previous year's 17.52 million. Losses were -2.75 million, 38.5% more than in 2023.